When was Noviocell founded?

Noviocell was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Noviocell located?

Noviocell is headquartered in Oss, Netherlands.

How many employees does Noviocell have?

As of Jul 01, 2024, the latest employee count at Noviocell is 1 - 10.

Is Noviocell a funded company?

Noviocell is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 01, 2016.

When was the latest funding round of Noviocell?

Noviocell's latest funding was a $***** Grant (prize money) round on Jan 01, 2017, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. Globally, the Life Sciences Platforms and Tools sector has seen $1.28B in funding in 2026 to date.

Where does Noviocell rank among its competitors?

Noviocell ranks 7th amongst 8 active competitors, of which 3 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Gel Coat Biomaterials, which secured $1.25M in Apr, 2026.

Who are the top competitors of Noviocell?

Noviocell's top competitors include Gel Coat Biomaterials, Likarda and Biogelx. Among them, Gel Coat Biomaterials secured the most recent funding round in April, 2026.

Noviocell - 2026 Company Profile, Funding & Competitors

Company Details

Developer of 3D cell culture technology for life science research. It offers proprietary hydrogel technologies the soft thermo-responsive helical oligo glycol polyisocyanopeptides hydrogel and the programmed self-assembly of peptide-modified cyclohexane triacid derivatives into self-assembled nanofibers for biomedical researchers, biotech and pharma industry and clinicians.

Key Metrics

Founded Year

2015

Location

Oss, Netherlands

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Jan 01, 2017, $*****

Investors

Europa

Ranked

7^th among 8 active competitors

Employee Count

1 - 10 as on Jul 01, 2024

Similar Companies

Gel Coat Biomaterials & 6 more

View Noviocell's full profile

Noviocell has raised funding over 2 rounds. Its first funding round was on Jun 01, 2016. Its latest funding round was a Grant (prize money) round on Jan 01, 2017 for $*****. 1 investor participated in its latest round. Noviocell has 1 institutional investor.

Here is the list of recent funding rounds of Noviocell:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2017	5840191	Grant (prize money)	7045620	4557227	8805539	2231763
Jun 01, 2016	1506937	Grant (prize money)	7773910	7530379	3704944	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Noviocell's funding rounds and investors

Noviocell's employee count trend

Noviocell has 1 - 10 employees as of Jul 24. Here is Noviocell's employee count trend over the years:

Uncover Noviocell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Noviocell include Gel Coat Biomaterials, Likarda and Biogelx. Here is the list of Top 10 competitors of Noviocell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gel Coat Biomaterials 2024, Chiyoda City (Japan), Seed	Developer of hydrogel technology related to biomaterials and medical applications	$2.59M	Soken Chem, WUV	46/100
2nd	Likarda 2012, Kansas City (United States), Series A	Developer of 3D cell cultures for regenerative medicine	$4M	Werth Ventures, HHS	42/100
3rd	Biogelx 2012, Lanark (United Kingdom), Seed	Supplies peptide hydrogels for cell culture	$983K	Scottish Enterprise, University of Strathclyde ... & 12 others	34/100
4th	Sumatrix Biotech 2021, Istanbul (Turkey), Unfunded	Manufacturer of hydrogel materials	-	-	26/100
5th	Matrix Bio 2023, Babraham (United Kingdom), Unfunded	Developer of hydrogel design platform for 3D cell culture applications	-	-	24/100
6th	SPES Tech 2019, Hong Kong (China), Unfunded	Develops recombinant protein hydrogel technology for cell culture	-	-	24/100
7th	Noviocell 2015, Oss (Netherlands), Funding Raised	Developer of 3D cell culture technology for life science research	-	Europa	16/100
8th	PepGel 2012, Manhattan (United States), Funding Raised	Cell culture solutions and innovative biomaterials for regenerative medicine research	-	National Science Foundation	13/100